<DOC>
	<DOC>NCT00818181</DOC>
	<brief_summary>This trial is performed to assess safety of a sublingual birch pollen extract.</brief_summary>
	<brief_title>Open Label Safety Study of a Birch Pollen Allergen Extract</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Allergic rhinoconjunctivitis attributable to birch pollen Positive SPT Positive EAST Serious chronic diseases Other perennial allergies Partly controlled asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Type I - Allergy, rhinoconjunctivitis</keyword>
</DOC>